4.9 (245) · € 14.99 · Auf Lager
Role of NK cells to treat B-Cell Lymphoma
Cancers, Free Full-Text
Onco, Free Full-Text
New treatment for non-Hodgkin B-cell lymphomas with a special focus on the impact of junctional adhesion molecules
Sources of NK cells. Current NK therapies use NK cells from the
CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity
JCM, Free Full-Text
Phase I/II Trial Shows Promising Results in Treatment of B-cell Malignancies
Norton Cancer Institute is one of 6 sites in the U.S. to host this human Phase 1 trial with natural killer cells. - Norton Healthcare Provider Louisville, Ky.